Molecular Research for Personalized Antitumoral Therapy
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (31 August 2023) | Viewed by 2126
Special Issue Editor
Interests: molecular pathology; neuro-oncology; hematopathology; molecular diagnosis in oncology
Special Issue Information
Dear Colleagues,
Precision oncology is no longer a futuristic approach to therapy as it has become an important part of clinical practice for physicians and scientists to assess diagnostic targets for personalized medicine. Although precision medicine is not a routinary path for most oncological patients, increased understanding of oncological diagnosis with genetics-based patient stratification will contribute to the future steps of precision oncology. Furthermore, the development of new antitumoral agents targeting specific genetic changes is a fundamental part of precision oncology, in particular for hematological malignancies, CNS glial neoplasms and head-and-neck tumors, as well as urothelial neoplasms.
In this context, this Special Issue aims to cover all sectors of research based on molecular patterns for antitumoral therapy. It will include original research, review articles, and short communications on specific molecular mechanisms of antitumoral agents, including conventional chemotherapeutical drugs, novel potential antitumoral drug candidates, and their combinations with any other antitumoral modalities.
Prof. Dr. Luigi Maria Larocca
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- precision oncology
- hematological malignancies
- CNS glial neoplasms
- head-and-neck tumors
- urothelial neoplasms
- antitumoral agents
- antitumoral therapy
